Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114787) titled 'An early clinical study to evaluate the safety and efficacy of ES-NK cell injection in the treatment of refractory lupus nephritis' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Condition:
Refractory lupus nephritis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-19
Target Sample Size: Experimental group:9;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299834
Published by HT Digital Con...